Margareth Dalcolmo Selected Research

Margareth Dalcolmo Research Topics

5	Tuberculosis (Tuberculoses) 01/2022 - 01/2016
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 09/2016
3	Extensively Drug-Resistant Tuberculosis 04/2018 - 01/2017
1	COVID-19 10/2021
1	Infections 01/2019
1	Lung Diseases (Lung Disease) 07/2018
1	Substance-Related Disorders (Drug Abuse) 07/2018
1	Coinfection 07/2018
1	Body Weight (Weight, Body) 01/2017
1	Pulmonary Tuberculosis 01/2016
1	HIV Infections (HIV Infection) 01/2012
1	Alcoholism (Alcohol Abuse) 01/2012

4	Pharmaceutical PreparationsIBA 01/2022 - 07/2017
3	Ethambutol (Myambutol)FDA LinkGeneric 07/2018 - 01/2012
3	Pyrazinamide FDA LinkGeneric 01/2017 - 01/2012
2	Streptomycin (Streptomycin Sulfate)FDA Link 07/2018 - 01/2012
2	Moxifloxacin (Avelox)FDA Link 07/2018 - 01/2016
2	bedaquiline (R207910)IBA 07/2017 - 01/2017
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2016 - 01/2012
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2016 - 01/2012
1	Levofloxacin (Levaquin)FDA Link 07/2018
1	OPC-67683IBA 07/2017
1	Clofazimine (Lamprene)FDA Link 01/2017
1	Oxygen (Dioxygen)IBA 09/2016
1	GasesIBA 09/2016
1	rifapentine (Priftin)FDA Link 01/2016
1	Antitubercular AgentsIBA 01/2016
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2012